These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
175 related articles for article (PubMed ID: 2406129)
21. Derivatives of blood coagulation factor IX contain a high affinity Ca2+-binding site that lacks gamma-carboxyglutamic acid. Morita T; Isaacs BS; Esmon CT; Johnson AE J Biol Chem; 1984 May; 259(9):5698-704. PubMed ID: 6425296 [TBL] [Abstract][Full Text] [Related]
22. The role of the epidermal growth factor-1 and hydrophobic stack domains of human factor IX in binding to endothelial cells. Cheung WF; Straight DL; Smith KJ; Lin SW; Roberts HR; Stafford DW J Biol Chem; 1991 May; 266(14):8797-800. PubMed ID: 1851159 [TBL] [Abstract][Full Text] [Related]
23. Structure and function of the epidermal growth factor domain of P-selectin. Freedman SJ; Sanford DG; Bachovchin WW; Furie BC; Baleja JD; Furie B Biochemistry; 1996 Oct; 35(43):13733-44. PubMed ID: 8901515 [TBL] [Abstract][Full Text] [Related]
24. Ca2+ binding to the first epidermal growth factor-like domain of human blood coagulation factor IX promotes enzyme activity and factor VIII light chain binding. Lenting PJ; Christophe OD; Maat H; Rees DJ; Mertens K J Biol Chem; 1996 Oct; 271(41):25332-7. PubMed ID: 8810297 [TBL] [Abstract][Full Text] [Related]
25. The structure of a Ca(2+)-binding epidermal growth factor-like domain: its role in protein-protein interactions. Rao Z; Handford P; Mayhew M; Knott V; Brownlee GG; Stuart D Cell; 1995 Jul; 82(1):131-41. PubMed ID: 7606779 [TBL] [Abstract][Full Text] [Related]
26. Construction, expression, and properties of a recombinant chimeric human protein C with replacement of its growth factor-like domains by those of human coagulation factor IX. Yu S; Zhang L; Jhingan A; Christiansen WT; Castellino FJ Biochemistry; 1994 Jan; 33(3):823-31. PubMed ID: 8292611 [TBL] [Abstract][Full Text] [Related]
28. The high affinity calcium-binding site involved in protein C activation is outside the first epidermal growth factor homology domain. Rezaie AR; Esmon NL; Esmon CT J Biol Chem; 1992 Jun; 267(17):11701-4. PubMed ID: 1601845 [TBL] [Abstract][Full Text] [Related]
29. Factor IXHollywood: substitution of Pro55 by Ala in the first epidermal growth factor-like domain. Spitzer SG; Kuppuswamy MN; Saini R; Kasper CK; Birktoft JJ; Bajaj SP Blood; 1990 Oct; 76(8):1530-7. PubMed ID: 2169923 [TBL] [Abstract][Full Text] [Related]
30. The epidermal growth factor-like domains of factor IX. Effect on blood clotting and endothelial cell binding of a fragment containing the epidermal growth factor-like domains linked to the gamma-carboxyglutamic acid region. Astermark J; Stenflo J J Biol Chem; 1991 Feb; 266(4):2438-43. PubMed ID: 1989995 [TBL] [Abstract][Full Text] [Related]
31. Chemical synthesis and characterization of the epidermal growth factor-like module of human complement protease C1r. Hernandez JF; Bersch B; Pétillot Y; Gagnon J; Arlaud GJ J Pept Res; 1997 Mar; 49(3):221-31. PubMed ID: 9151255 [TBL] [Abstract][Full Text] [Related]
32. In vitro gamma-carboxylation of a 59-residue recombinant peptide including the propeptide and the gamma-carboxyglutamic acid domain of coagulation factor IX. Effect of mutations near the propeptide cleavage site. Wu SM; Soute BA; Vermeer C; Stafford DW J Biol Chem; 1990 Aug; 265(22):13124-9. PubMed ID: 2198285 [TBL] [Abstract][Full Text] [Related]
33. The N-terminal epidermal growth factor-like domain of coagulation factor IX. Probing its functions in the activation of factor IX and factor X with a monoclonal antibody. Persson KE; Villoutreix BO; Thämlitz AM; Knobe KE; Stenflo J J Biol Chem; 2002 Sep; 277(38):35616-24. PubMed ID: 12105230 [TBL] [Abstract][Full Text] [Related]
34. The three-dimensional structure of the first EGF-like module of human factor IX: comparison with EGF and TGF-alpha. Baron M; Norman DG; Harvey TS; Handford PA; Mayhew M; Tse AG; Brownlee GG; Campbell ID Protein Sci; 1992 Jan; 1(1):81-90. PubMed ID: 1304885 [TBL] [Abstract][Full Text] [Related]
35. Blood coagulation factor IX residues Glu78 and Arg94 provide a link between both epidermal growth factor-like domains that is crucial in the interaction with factor VIII light chain. Christophe OD; Lenting PJ; Kolkman JA; Brownlee GG; Mertens K J Biol Chem; 1998 Jan; 273(1):222-7. PubMed ID: 9417068 [TBL] [Abstract][Full Text] [Related]
36. Expression and characterization of human factor IX and factor IX-factor X chimeras in mouse C127 cells. Lin SW; Smith KJ; Welsch D; Stafford DW J Biol Chem; 1990 Jan; 265(1):144-50. PubMed ID: 2294100 [TBL] [Abstract][Full Text] [Related]
37. Construction, expression, and characterization of a chimera of factor IX and factor X. The role of the second epidermal growth factor domain and serine protease domain in factor Va binding. Hertzberg MS; Ben-Tal O; Furie B; Furie BC J Biol Chem; 1992 Jul; 267(21):14759-66. PubMed ID: 1634519 [TBL] [Abstract][Full Text] [Related]
38. Identification of the phospholipid binding site in the vitamin K-dependent blood coagulation protein factor IX. Freedman SJ; Blostein MD; Baleja JD; Jacobs M; Furie BC; Furie B J Biol Chem; 1996 Jul; 271(27):16227-36. PubMed ID: 8663165 [TBL] [Abstract][Full Text] [Related]
39. Characterization of the EGF-like module pair 3-4 from vitamin K-dependent protein S using NMR spectroscopy reveals dynamics on three separate time scales and extensive effects from calcium binding. Muranyi A; Evenäs J; Stenberg Y; Stenflo J; Drakenberg T Biochemistry; 2000 Dec; 39(51):15742-56. PubMed ID: 11123899 [TBL] [Abstract][Full Text] [Related]
40. Localization of a metal-dependent epitope to the amino terminal residues 33-40 of human factor IX. Cheung WF; Wolberg AS; Stafford DW; Smith KJ Thromb Res; 1995 Dec; 80(5):419-27. PubMed ID: 8588203 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]